Sexual side-effects of contemporary antidepressants: Review

Australian and New Zealand Journal of Psychiatry

Volumn 43, Issue 9, 2009, Pages 795-808

  Schweitzer, Isaac ^a,b   Maguire, Kay ^a   Ng, Chee ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b The Melbourne Clinic   (Australia)

^c Professorial Unit   (Australia)

Author keywords

Antidepressants; Depression; Dysfunction; Sexual; Side effects

Indexed keywords

AGOMELATINE; AMANTADINE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; CYPROHEPTADINE; DESVENLAFAXINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PLACEBO; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TADALAFIL; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VARDENAFIL; VENLAFAXINE;

ALCOHOL ABUSE; ANORGASMIA; AUSTRALIA; BORDERLINE STATE; CLINICAL TRIAL; COMORBIDITY; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; DYSPAREUNIA; EJACULATION DISORDER; ERECTILE DYSFUNCTION; HUMAN; IMPOTENCE; LIBIDO; LIBIDO DISORDER; MAJOR DEPRESSION; NONHUMAN; ORGASM; ORGASM DISORDER; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT EDUCATION; PREMATURE EJACULATION; PRIAPISM; RATING SCALE; REVIEW; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUAL DESIRE; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SIDE EFFECT;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 69449101962     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670903107575     Document Type: Review

References (40)

1. Saks BR, Gillespie MA. Psychotropic medication and sexual function in women: An update. Arch Womens Ment Health 2002; 4:139-144.
2. Segraves R. Sexual dysfunction associated with antidepressant therapy. Urol Clin North Am 2007; 34:575-579.
3. Werneke U, Northey S, Bhugra D. Antidepressants and sexual dysfunction. Acta Psychiatr Scand 2006; 114:384-397.
4. Montejo-Gonzalez A, Llorca G, Izquierdo J et al. SSRIinduced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicentre and descriptive clinical study of 344 patients. J Sex Marital Ther 1997; 23:176-194.
5. Segraves R. Recognising and reversing sexual side effects of medications. In: Levine SC, Risen C, Althof S, eds. Handbook of clinical sexuality for mental health professionals. New York, NY: Brunner-Routledge, 2003:377-392.
6. Segraves R, Kavoussi R, Hughes A et al. Evaluation of sexual functioning in depressed outpatients: A double-blind comparison of sustained-release bupropion and sertraline treatment. J Clin Psychopharmacol 2000; 20:122-128.
7. Bonierbale M, Lancon C, Tignol J. The ELIXIR study: Evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin 2003; 19:114-124.
8. Berk M, Acton M. Citalopram associated with clitoral priapism: A case series. Int Clin Psychopharmacol 1997; 12:121-123.
9. Leiblum S, Goldmeier D. Persistent genital arousal disorder in women: case reports of association with antidepressant usage and withdrawal. J Sex Marital Ther 2008; 34:150-159.
10. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: Comparative effectiveness and harms of treatments for clinically localised prostate cancer. Ann Intern Med 2008; 148:435-448.
11. Nehra A. Selecting therapy for maintaining sexual function in patients with benign prostatic hyperplasia. BJU Int 2005; 96:237-243.
12. Smith S. Drugs that cause sexual dysfunction. Psychiatry 2007; 6:111-114.
13. Westenburg HGM, Sandner C. Tolerability and safety of fluvoxamine and other antidepressants. Int J Clin Pract 2006; 60:482-491.
14. Monteiro W, Noshirvani N, Marks I. Anorgasmia from clomipramine in obsessive compulsive disorder: A controlled trial. Br J Psychiatry 1987; 151:107-112.
15. Philipp M, Tiller JWG, Baier D, Kohnen R. Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. Eur Neuropsychopharmacol 2000; 10:305-314.
16. Clayton AH, Pradko JF, Croft HA et al. Prevalence of sexual dysfunction among newer antidepressants J Clin Psychiatry 2002; 63:357-366.
17. Haberfellner EM. A review of the assessment of antidepressant-induced sexual dysfunction used in randomised, controlled clinical trials. Pharmacopsychiatry 2007; 40:173-182.
18. Thase ME, Clayton AH, Haight BR, Thompson AH, Modell JG, Johnston JA. A double-blind comparison between bupropion XL and venlafaxine XR. J Clin Psychopharmacol 2006; 26:482-488.
19. Kennedy SH, Rizvi S, Fulton K, Rasmussen J. A doubleblind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. J Clin Psychopharmacol 2008; 28:329-333.
20. Clayton AH, Zajecka J, Ferguson JM, Filipiak-Reisner JK, Brown MT, Schwartz GE. Lackof sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol 2003; 18:151-156.
21. Langworth S, Bodlund O, Agren S. Efficacy and tolerability of reboxetine compared with citalopram. J Clin Psychopharmacol 2006; 26:121-127.
22. Behnke K, Sogaard J, Martin S et al. Mirtazepine orally disintegrating tablet versus sertraline: A prospective onset of action study. J Clin Psychopharmacol 2003; 23:358-364.
23. Delgado PL, Brannan SK, Mallinckrodt CH et al. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 2005; 66:686-692.
24. Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M. Changes in sexual functioning associated with duloxetine, escitalopram and placebo in the treatment of patients with major depressive disorder. J Sex Med 2007; 4:917-929.
25. Croft H, Settle E, Houser T, Batey SR, Donahue RMJ, Ascher JA. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 1999; 21:643-658.
26. Coleman CC, Cunningham LA, Foster VJ et al. Sexual dysfunction associated with the treatment of depression: A placebo-controlled comparison of bupropion sustained release and sertraline treatment. Ann Clin Psychiatry 1999; 11:205-215.
27. Coleman CC, King BR, Bolden-Watson C et al. A placebocontrolled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther 2001; 23: 1040-1058.
28. Clayton AH, Croft HA, Horrigan JP et al. Bupropion extended release compared with escitalopram: Effects on sexual functioning and antidepressant efficacy in 2 randomised, double-blind, placebo-controlled studies. J Clin Psychiatry 2006; 67:736-746.
29. Kennedy SH, Fulton KA, Bagby RM, Greene AL, Cohen NL, Rafi-Tari S. Sexual function during bupropion or paroxetine treatment of major depressive disorder. Can J Psychiatry 2006; 52:234-242.
30. Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline and venlafaxine. J Clin Psychiatry 2000; 61:276-281.
31. Baldwin D, Bridgman K, Buis C. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine. J Psychopharmacol 2006; 20:91-96.
32. Wade A, Crawford GM, Angus M, Wilson R, Hamilton L. A randomised, double-blind, 24-week study comparing the efficacy and tolerability of mirtazepine and paroxetine in depressed patients in primary care. Int Clin Psychopharmacol 2003; 18:133-141.
33. Versiani M, Moreno R, Ramakers-van Moorsel CJA, Schutte AJ. Comparison of the effects of mirtazepine and fluoxetine in severely depressed patients. CNS Drugs 2005; 19:137-146.
34. Siaz-Ruiz J, Montes JM, Ibanez A et al. Assessment of sexual functioning in depressed patients treated with mirtazepine: A naturalistic 6-month study. Hum Psychopharmacol Clin Exp 2005; 20:435-440.
35. Thase ME, Haight BR, Richard N et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: A meta-analysis of original data from 7 randomised controlled trials. J Clin Psychiatry 2005; 66:974-981.
36. Lieberman DZ, Montgomery SA, Tourian KA et al. A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder. Int Clin Psychopharmacol 2008; 23:188-197.
37. Montejo AL, Prieto N, Terleira A et al. Better sexual acceptability of agomelatine compared to paroxetine in healthy male volunteers using the PRSexDQ scale. Eur J Neuropsychopharmacol 2008; 17:S349.
38. Makhlouf A, Kparker A, Niederberger CS. Depression and erectile dysfunction. Urol Clin North Am 2007; 34:565-574.
39. Nurnberg HG, Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: A randomised controlled trial. JAMA 2008; 300:395-404.
40. Taylor MJ, Rudkin L, Hawton K. Strategies for managing antidepressant-induced sexual dysfunction: Systematic review of randomised controlled trials. J Affect Disord 2005; 88:241-254.